China Retinal Drugs and Biologics Market Research Report 2018

March 2018 | 108 pages | ID: CB44BF60015EN
QYResearch

Abstracts

The global Retinal Drugs and Biologics market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Retinal Drugs and Biologics development status and future trend in China, focuses on top players in China, also splits Retinal Drugs and Biologics by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Alimera Sciences
• Janssen Biotech
• F. Hoffmann-La Roche Ltd
• Genzyme Corporation
• Ocular Therapeutix
• UCBCares
• Allergan
• AbbVie Inc
• Swedish Orphan Biovitrum
• Bristol-Myers Squibb Company
• Genentech USA
• Bausch & Lomb Incorporated

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Surgery
• Medicines
• Retinal Laser
• Others

On the basis of the end users/application, this report covers

• Hospital Pharmacies
• Retail Pharmacies
• Specialty Ophthalmology Clinics
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Retinal Drugs and Biologics Market Research Report 2018

1 RETINAL DRUGS AND BIOLOGICS OVERVIEW

1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Classification of Retinal Drugs and Biologics by Product Category
  1.2.1 China Retinal Drugs and Biologics Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Retinal Drugs and Biologics Sales (K Units) Market Share by Type in 2017
  1.2.3 Surgery
  1.2.4 Medicines
  1.2.5 Retinal Laser
  1.2.6 Others
1.3 China Retinal Drugs and Biologics Market by Application/End Users
  1.3.1 China Retinal Drugs and Biologics Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Specialty Ophthalmology Clinics
  1.3.5 Others
1.4 China Retinal Drugs and Biologics Market by Region
  1.4.1 China Retinal Drugs and Biologics Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.3 East China Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.4 Southwest China Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.5 Northeast China Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.6 North China Retinal Drugs and Biologics Status and Prospect (2013-2025)
  1.4.7 Central China Retinal Drugs and Biologics Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Retinal Drugs and Biologics (2013-2025)
  1.5.1 China Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA RETINAL DRUGS AND BIOLOGICS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Retinal Drugs and Biologics Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Retinal Drugs and Biologics Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Retinal Drugs and Biologics Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Retinal Drugs and Biologics Market Competitive Situation and Trends
  2.4.1 China Retinal Drugs and Biologics Market Concentration Rate
  2.4.2 China Retinal Drugs and Biologics Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Retinal Drugs and Biologics Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA RETINAL DRUGS AND BIOLOGICS SALES AND REVENUE BY REGION (2013-2018)

3.1 China Retinal Drugs and Biologics Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Retinal Drugs and Biologics Price (USD/Unit) by Regions (2013-2018)

4 CHINA RETINAL DRUGS AND BIOLOGICS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Retinal Drugs and Biologics Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Retinal Drugs and Biologics Price (USD/Unit) by Type (2013-2018)
4.4 China Retinal Drugs and Biologics Sales Growth Rate (%) by Type (2013-2018)

5 CHINA RETINAL DRUGS AND BIOLOGICS SALES BY APPLICATION (2013-2018)

5.1 China Retinal Drugs and Biologics Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Retinal Drugs and Biologics Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA RETINAL DRUGS AND BIOLOGICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alimera Sciences
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alimera Sciences Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Janssen Biotech
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Janssen Biotech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 F. Hoffmann-La Roche Ltd
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Genzyme Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Genzyme Corporation Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Ocular Therapeutix
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 UCBCares
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 UCBCares Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Allergan
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Allergan Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 AbbVie Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AbbVie Inc Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Swedish Orphan Biovitrum
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Bristol-Myers Squibb Company
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Retinal Drugs and Biologics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Genentech USA
6.12 Bausch & Lomb Incorporated

7 RETINAL DRUGS AND BIOLOGICS MANUFACTURING COST ANALYSIS

7.1 Retinal Drugs and Biologics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Retinal Drugs and Biologics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Retinal Drugs and Biologics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA RETINAL DRUGS AND BIOLOGICS MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Retinal Drugs and Biologics Sales (K Units) Forecast by Type (2018-2025)
11.3 China Retinal Drugs and Biologics Sales (K Units) Forecast by Application (2018-2025)
11.4 China Retinal Drugs and Biologics Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Retinal Drugs and Biologics Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Retinal Drugs and Biologics Sales (K Units) by Application (2013-2025)
Figure Product Picture of Retinal Drugs and Biologics
Table China Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Retinal Drugs and Biologics Sales Volume Market Share by Types in 2017
Figure Surgery Product Picture
Figure Medicines Product Picture
Figure Retinal Laser Product Picture
Figure Others Product Picture
Figure China Retinal Drugs and Biologics Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Retinal Drugs and Biologics by Application in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Specialty Ophthalmology Clinics Examples
Table Key Downstream Customer in Specialty Ophthalmology Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Retinal Drugs and Biologics Sales of Key Players/Manufacturers (2013-2018)
Table China Retinal Drugs and Biologics Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Retinal Drugs and Biologics Sales Share (%) by Players/Manufacturers
Figure 2017 China Retinal Drugs and Biologics Sales Share (%) by Players/Manufacturers
Table China Retinal Drugs and Biologics Revenue by Players/Manufacturers (2013-2018)
Table China Retinal Drugs and Biologics Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Retinal Drugs and Biologics Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Retinal Drugs and Biologics Revenue Market Share (%) by Players/Manufacturers
Table China Market Retinal Drugs and Biologics Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Retinal Drugs and Biologics Average Price of Key Players/Manufacturers in 2017
Figure China Retinal Drugs and Biologics Market Share of Top 3 Players/Manufacturers
Figure China Retinal Drugs and Biologics Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Retinal Drugs and Biologics Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Retinal Drugs and Biologics Product Category
Table China Retinal Drugs and Biologics Sales (K Units) by Regions (2013-2018)
Table China Retinal Drugs and Biologics Sales Share (%) by Regions (2013-2018)
Figure China Retinal Drugs and Biologics Sales Share (%) by Regions (2013-2018)
Figure China Retinal Drugs and Biologics Sales Market Share (%) by Regions in 2017
Table China Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Retinal Drugs and Biologics Revenue Market Share (%) by Regions (2013-2018)
Figure China Retinal Drugs and Biologics Revenue Market Share (%) by Regions (2013-2018)
Figure China Retinal Drugs and Biologics Revenue Market Share (%) by Regions in 2017
Table China Retinal Drugs and Biologics Price (USD/Unit) by Regions (2013-2018)
Table China Retinal Drugs and Biologics Sales (K Units) by Type (2013-2018)
Table China Retinal Drugs and Biologics Sales Share (%) by Type (2013-2018)
Figure China Retinal Drugs and Biologics Sales Share (%) by Type (2013-2018)
Figure China Retinal Drugs and Biologics Sales Market Share (%) by Type in 2017
Table China Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Retinal Drugs and Biologics Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Retinal Drugs and Biologics by Type (2013-2018)
Figure Revenue Market Share of Retinal Drugs and Biologics by Type in 2017
Table China Retinal Drugs and Biologics Price (USD/Unit) by Types (2013-2018)
Figure China Retinal Drugs and Biologics Sales Growth Rate (%) by Type (2013-2018)
Table China Retinal Drugs and Biologics Sales (K Units) by Applications (2013-2018)
Table China Retinal Drugs and Biologics Sales Market Share (%) by Applications (2013-2018)
Figure China Retinal Drugs and Biologics Sales Market Share (%) by Application (2013-2018)
Figure China Retinal Drugs and Biologics Sales Market Share (%) by Application in 2017
Table China Retinal Drugs and Biologics Sales Growth Rate (%) by Application (2013-2018)
Figure China Retinal Drugs and Biologics Sales Growth Rate (%) by Application (2013-2018)
Table Alimera Sciences Retinal Drugs and Biologics Basic Information List
Table Alimera Sciences Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Alimera Sciences Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Alimera Sciences Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure Alimera Sciences Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table Janssen Biotech Retinal Drugs and Biologics Basic Information List
Table Janssen Biotech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Janssen Biotech Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Janssen Biotech Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure Janssen Biotech Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Basic Information List
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table Genzyme Corporation Retinal Drugs and Biologics Basic Information List
Table Genzyme Corporation Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure Genzyme Corporation Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table Ocular Therapeutix Retinal Drugs and Biologics Basic Information List
Table Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure Ocular Therapeutix Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table UCBCares Retinal Drugs and Biologics Basic Information List
Table UCBCares Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure UCBCares Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure UCBCares Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure UCBCares Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table Allergan Retinal Drugs and Biologics Basic Information List
Table Allergan Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Allergan Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Allergan Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure Allergan Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table AbbVie Inc Retinal Drugs and Biologics Basic Information List
Table AbbVie Inc Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AbbVie Inc Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AbbVie Inc Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure AbbVie Inc Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Basic Information List
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Basic Information List
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales Market Share (%) in China (2013-2018)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Revenue Market Share (%) in China (2013-2018)
Table Genentech USA Retinal Drugs and Biologics Basic Information List
Table Bausch & Lomb Incorporated Retinal Drugs and Biologics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Retinal Drugs and Biologics
Figure Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure Retinal Drugs and Biologics Industrial Chain Analysis
Table Raw Materials Sources of Retinal Drugs and Biologics Major Players/Manufacturers in 2017
Table Major Buyers of Retinal Drugs and Biologics
Table Distributors/Traders List
Figure China Retinal Drugs and Biologics Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Retinal Drugs and Biologics Price (USD/Unit) Trend Forecast (2018-2025)
Table China Retinal Drugs and Biologics Sales (K Units) Forecast by Type (2018-2025)
Figure China Retinal Drugs and Biologics Sales (K Units) Forecast by Type (2018-2025)
Figure China Retinal Drugs and Biologics Sales Volume Market Share Forecast by Type in 2025
Table China Retinal Drugs and Biologics Sales (K Units) Forecast by Application (2018-2025)
Figure China Retinal Drugs and Biologics Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Retinal Drugs and Biologics Sales Volume Market Share Forecast by Application in 2025
Table China Retinal Drugs and Biologics Sales (K Units) Forecast by Regions (2018-2025)
Table China Retinal Drugs and Biologics Sales Volume Share Forecast by Regions (2018-2025)
Figure China Retinal Drugs and Biologics Sales Volume Share Forecast by Regions (2018-2025)
Figure China Retinal Drugs and Biologics Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources